Take Control of Your Lung Cancer Journey with Advanced EGFR Testing
Facing a lung cancer diagnosis can feel overwhelming, but knowing your specific genetic mutations gives you power. Our liquid biopsy EGFR test provides crucial information about your cancer’s genetic profile without invasive procedures, helping you and your doctor make informed treatment decisions that could significantly improve your outcomes.
Understanding Your EGFR Mutation Test
This advanced blood test detects specific EGFR mutations (T790M, L858R, and Exon 19 deletion) that are common in non-small cell lung cancer. Unlike traditional tissue biopsies that require invasive procedures, our liquid biopsy uses a simple blood draw to analyse cancer DNA circulating in your bloodstream. This innovative approach provides the same critical information with less discomfort and faster results.
Who Should Consider This Test?
This test is particularly important if you:
- Have been diagnosed with non-small cell lung cancer
- Are experiencing progression after initial EGFR-targeted therapy
- Need to monitor treatment response without repeated invasive biopsies
- Want to determine eligibility for specific targeted therapies
- Prefer a less invasive alternative to tissue sampling
Early detection of these mutations can guide your treatment toward more effective options, potentially avoiding therapies that won’t work for your specific cancer type.
Why This Test Matters for Your Treatment Journey
Knowing your EGFR mutation status transforms your cancer care by:
- Guiding Targeted Therapy: Determine if you’ll respond to EGFR inhibitor drugs
- Monitoring Resistance: Detect T790M mutations that cause treatment resistance
- Avoiding Ineffective Treatment: Save time and avoid side effects from therapies that won’t work
- Personalised Care: Receive treatment tailored to your cancer’s genetic makeup
- Peace of Mind: Make informed decisions with comprehensive genetic information
Understanding Your Results with Confidence
Your results will clearly indicate whether T790M, L858R, or Exon 19 deletion mutations are present. Our medical team provides easy-to-understand explanations, and we recommend discussing results with your oncologist to determine the best treatment path. Positive results for specific mutations may qualify you for targeted therapies that can be more effective and have fewer side effects than traditional chemotherapy.
Transparent Pricing – Exceptional Value
| Test Description | Regular Price | Special Price | Turnaround Time |
|---|---|---|---|
| Liquid Biopsy EGFR Mutation Test | ZAR 5,000 | 5-7 days |
This investment in your health could save you from costly, ineffective treatments and provide the clarity needed for targeted, successful therapy.
Why Trust Oracle Genomics?
- Nationwide Coverage: Available in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Medical Expertise: Conducted by experienced oncology specialists
- Advanced Technology: Using Droplet Digital PCR for superior accuracy
- Patient-Focused Care: Compassionate support throughout your testing journey
- Reliable Results: Trusted by healthcare professionals nationwide
Take the Next Step in Your Cancer Care
Don’t leave your treatment decisions to chance. Knowing your EGFR status could be the key to more effective, targeted therapy. With our special price of ZAR 5,000 and quick 5-7 day turnaround, there’s no reason to delay this crucial testing.
Note: A doctor’s prescription is required for this test, except for surgery preparation, pregnancy cases, or travel abroad documentation.
Early detection saves lives. Book your EGFR test today and take control of your cancer treatment journey with confidence and clarity.
